Exubera, the new inhaled insulin
July 2006
Patients will soon be trying Exubera, the new inhaled insulin.
Exubera is an alternative to short-acting or regular insulin... for patients with either type 1 or type 2 diabetes.
It has a fast onset...for use up to 10 minutes before meals.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote